Ligand validation:8TBS

HVI: 6-[(6-aminopyridin-2-yl)methyl]-4-methyl-2-[(1H-pyrazol-3-yl)methyl]-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one

HVI is a Ligand Of Interest in 8TBS designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TBS_HVI_D_601	71%	7%	0.143	0.966	2.4	2.53	7	8	0	0	100%	1
8TBS_HVI_F_601	70%	8%	0.151	0.97	2.35	2.5	7	9	0	0	100%	1
8TBS_HVI_H_601	69%	7%	0.144	0.961	2.36	2.55	8	10	0	0	100%	1
8TBS_HVI_B_601	60%	7%	0.156	0.942	2.47	2.55	8	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.